Influenza in the elderly - A mini-review

Gerontology

Volumn 57, Issue 5, 2011, Pages 397-404

  Pop Vicas, A ^a   Gravenstein, S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Influenza; Influenza vaccine

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; PERAMIVIR; RIMANTADINE; ZANAMIVIR;

ADAPTIVE IMMUNITY; AGED; AGING; ASTHMA; BACTERIAL PNEUMONIA; CAREGIVER; CHRONIC BRONCHITIS; COUGHING; GERIATRIC PATIENT; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOST RESISTANCE; HUMAN; IMMUNOFLUORESCENCE; INFLUENZA; INFLUENZA VACCINATION; INNATE IMMUNITY; LABORATORY TEST; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RAPID ANTIGEN TEST; REVIEW; SEROLOGY; SNEEZING; VIRUS CULTURE; VIRUS IMMUNITY; VIRUS PNEUMONIA; VIRUS SHEDDING; VIRUS TRANSMISSION;

AGED; AGING; COST OF ILLNESS; EARLY MEDICAL INTERVENTION; FEMALE; FRAIL ELDERLY; HEALTH SERVICES FOR THE AGED; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PREVENTIVE HEALTH SERVICES; VIRUS SHEDDING;

EID: 80052496022     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000319033     Document Type: Review

References (54)

1. Thompson WW, et al: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186. (Pubitemid 36068705)
2. Thompson WW, et al: Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-1340. (Pubitemid 39223224)
3. Barker WH, Borisute H, Cox C: A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 1998; 158: 645-650. (Pubitemid 28144823)
4. Covinsky KE, et al: Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: Increased vulnerability with age. J Am Geriatr Soc 2003; 51: 451-458. (Pubitemid 36457342)
5. Hancock K, et al: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 1945-1952.
6. Louie JK, et al: Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009; 302: 1896-1902.
7. Treanor JJ: Influenza viruses, including avian influenza and swine influenza; in Mandell GL, Bennett JE, Dolin R (eds): Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, Churchill Livingstone, 2009, pp 2265-2288.
8. Carrat F, et al: Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am J Epidemiol 2008; 167: 775-785. (Pubitemid 351451744)
9. Lee N, et al: Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200: 492-500.
10. Gravenstein S, et al: Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. J Am Med Dir Assoc 2005; 6: 359-366. (Pubitemid 41755354)
11. Husseini RH, et al: Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. J Infect Dis 1982; 145: 520-524. (Pubitemid 12158339)
12. Ramphal R, et al: Murine influenzal tracheitis: A model for the study of influenza and tracheal epithelial repair. Am Rev Respir Dis 1979; 120: 1313-1424.
13. Mauad T, et al: Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010; 181: 72-79.
14. Yewdell JW, et al: Influenza A virus nucleoprotein is a major target antigen for crossreactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1985; 82: 1785-1789. (Pubitemid 15085262)
15. McMichael AJ, et al: Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309: 13-17. (Pubitemid 13062888)
16. Renshaw M, et al: Cutting edge: Impaired Toll-like receptor expression and function in aging. J Immunol 2002; 169: 4697-4701. (Pubitemid 35217128)
17. Deng Y, et al: Age-related impaired type 1 T cell responses to influenza: Reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004; 172: 3437-3446. (Pubitemid 38337923)
18. McElhaney JE: Prevention of infectious diseases in older adults through immunization: The challenge of the senescent immune response. Expert Rev Vaccines 2009; 8: 593-606.
19. Saurwein-Teissl M, et al: Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168: 5893-5899. (Pubitemid 34556178)
20. McElhaney JE, et al: Immune response to influenza vaccination in institutionalized elderly: Effect on different T-cell subsets. Vaccine 1998; 16: 403-409. (Pubitemid 28012253)
21. Walsh EE, Cox C, Falsey AR: Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc 2002; 50: 1498-1503. (Pubitemid 35024641)
22. Louria DB, et al: Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959; 38(1 Part 2):213-265.
23. Bentley DW: Bacterial pneumonia in the elderly: Clinical features, diagnosis, etiology, and treatment. Gerontology 1984; 30: 297-307. (Pubitemid 14000538)
24. Centers for Disease Control and Prevention (CDC): Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States May- August 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 1071-1074.
25. Nichol KL, et al: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-1332. (Pubitemid 36384099)
26. Monto AS, et al: Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000; 160: 3243-3247.
27. Faix DJ, Sherman SS, Waterman SH: Rapidtest sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 361: 728-729.
28. United States Center for Disease Control and Prevention: Interim guidance on specimen collection, processing, and testing for patients with suspected swine-origin influenza A (H1N1) virus infection. 2009. http://www. cdc.gov/h1n1f lu/specimencollection.htm (accessed July 24, 2009).
29. Pollock NR, et al: Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing. Clin Infect Dis 2009; 49:e66-e68.
30. Harper SA, et al: Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1003-1032.
31. Webb SA, et al: Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361: 1925-1934.
32. Ison MG: Influenza in hospitalized adults: Gaining insight into a significant problem. J Infect Dis 2009; 200: 485-488.
33. Birnkrant D, Cox E: The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009; 361: 2204-2207.
34. World Health Organization: Antiviral use and the risk of drug resistance. Pandemic (H1N1) 2009 briefing note 12; 29 September, 2009. http://www.who.int/ csr/disease/swinef lu/notes/h1n1-antiviral-use-20090925/en/index.html (cited February 11, 2010).
35. Fiore AE, et al: Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58(RR-8):1-52.
36. Govaert TM, et al: The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-1665.
37. Rivetti D, et al: Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006; 3:CD004876.
38. Jefferson T, et al: Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review. Lancet 2005; 366: 1165-1174. (Pubitemid 41393594)
39. Ahmed AE, Nicholson KG, Nguyen-Van- Tam HS: Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995; 346: 591-595.
40. Voordouw AC, et al: Annual revaccination against influenza and mortality risk in community- dwelling elderly persons. JAMA 2004; 292: 2089-2095. (Pubitemid 39435099)
41. Simonsen L, et al: Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165: 265-272. (Pubitemid 40216277)
42. Kelly H, Vu T, Smith D: Influenza vaccination and mortality in the United States. Arch Intern Med 2005; 165: 2037-2038; author reply 2039-2040. (Pubitemid 41362630)
43. Thompson WW, et al: Influenza vaccination among the elderly in the United States. Arch Intern Med 2005; 165: 2038-2039; author reply 2039-2040.
44. Holland D, et al: Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial. J Infect Dis 2008; 198: 650-658.
45. Chi RC, Rock MT, Neuzil KM: Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010; 50: 1331-1338.
46. Iob A, et al: Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy. Epidemiol Infect 2005; 133: 687-693. (Pubitemid 41015560)
47. Falsey AR, et al: Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standarddose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200: 172-180.
48. Centers for Disease Control and Prevention (CDC): Licensure of a high-dose inactivated influenza vaccine for persons aged 1 or =65 years (Fluzone High-Dose) and guidance for use - United States, 2010. MMWR Morb Mortal Wkly Rep 2010; 59: 485-486.
49. Weycker D, et al: Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23: 1284-1293. (Pubitemid 40126532)
50. Ghendon YZ, Kaira AN, Elshina GA: The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134: 71-78. (Pubitemid 43103531)
51. Reichert TA, et al: The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344: 889-896. (Pubitemid 32224397)
52. Carman WF, et al: Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomised controlled trial. Lancet 2000; 355: 93-97. (Pubitemid 30068552)
53. Vajo Z, et al: Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: A multicentre, randomised controlled trial. Lancet 2010; 375: 49-55.
54. Perez-Padilla R, et al: Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-689.